If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

TAE Life Sciences is developing a next-generation boron neutron capture therapy for cancer. After recently introducing Alphabeam, a compact and affordable accelerator-based neutron system suitable ...

Boron neutron capture therapy is being used in Japan to target ... interaction between boron in the tumour and neutrons in the beam that releases a strong radiation locally, minimizing damage ...

Boston biotech Beam Therapeutics has announced initial data from a phase 1/2 trial of its gene therapy for a genetic lung and liver disease, with no serious adverse events reported among the nine ...

Boron Neutron Capture Therapy (BNCT) Market is Segmented by Type (Thermal Beam, Epithermal Beam), by Application (Brain Tumor, Extracranial Tumor). Claim Your Free Report: https://reports.valuates ...

A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns ...

BEAM-302 showed durable, dose-dependent correction of AATD mutation in 9 patients with effects seen as early as Day 7. Beam plans further dose escalation and will report new trial data in H2 2025 ...